Trials / Sponsors / John Rieth
John Rieth
Academic / Other · 4 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | Neoadjuvant Intralesional Injection of Talimogene Laherparepvec Soft Tissue Sarcoma, Sarcoma,Soft Tissue | Phase 2 | 2025-03-03 |
| Recruiting | Palbociclib and Pembrolizumab in Sarcoma Sarcoma | Phase 1 | 2024-02-01 |
| Active Not Recruiting | TVEC and Preop Radiation for Sarcoma (8 ml Dose) Soft Tissue Sarcoma | Phase 1 / Phase 2 | 2020-09-10 |
| Terminated | Cabozantinib and Pembrolizumab for Advanced Metastatic Melanoma Advanced Metastatic Melanoma | Phase 1 / Phase 2 | 2019-08-27 |